Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA recalls 580K prazosin bottles over cancer-linked impurity; no illnesses reported.
The U.S. FDA has recalled over 580,000 bottles of prazosin, a blood pressure medication, due to contamination with N-nitroso prazosin impurity C, a nitrosamine linked to cancer in animal studies.
The recall affects 1 mg, 2 mg, and 5 mg capsules from specific lots distributed nationwide, with no illnesses reported.
Classified as a Class II recall, the risk of serious harm is low, but long-term exposure above safety limits may increase cancer risk.
Patients should not stop taking the medication abruptly, as this could lead to rebound hypertension or other complications.
They are advised to check their medication’s lot number, consult their healthcare provider, and discuss safe alternatives.
The recall follows similar actions on other drugs, highlighting ongoing concerns about nitrosamine contamination in pharmaceuticals.
La FDA retira 580K botellas de prazosina por impurezas relacionadas con el cáncer; no se reportaron enfermedades.